CLB

$9.552.25%-0.22

Nachbörslich: 9.77+0.22 +2.30%

Core Laboratories Inc (CLB)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$9.77

Offen:

$9.85

24-Stunden-Volumen:

130,658

Relatives Volumen:

0.16

Marktkapitalisierung:

$437.61M

Einnahmen:

$524.73M

Nettoeinkommen (Verlust:

$31.70M

KGV:

14.43

EPS:

$0.6617

Netto-Cashflow:

$22.47M

1W Leistung:

-8.96%

1M Leistung:

-3.73%

6M Leistung:

-30.70%

1Y Leistung:

-39.67%

1-Tages-Spanne:

$9.54$9.88

1-Wochen-Bereich:

$9.47$10.79

52-Wochen-Spanne:

$9.13$20.36

Core Laboratories Inc Aktie (CLB) Unternehmensprofil

Firmenname

Core Laboratories Inc

Sektor

Energy

Branche

Oil & Gas Equipment & Services

Telefon

713-328-2673

Adresse

6316 WINDFERN ROAD, HOUSTON, USA

Mitarbeiter

3,300

@corelabcompany

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

CLB-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Core Laboratories Inc Aktie (CLB) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-08-13	Hochstufung	Johnson Rice	Hold → Buy
2025-03-12	Hochstufung	Citigroup	Sell → Neutral
2023-06-30	Herabstufung	Citigroup	Neutral → Sell
2023-04-18	Herabstufung	BofA Securities	Neutral → Underperform
2023-01-09	Hochstufung	BofA Securities	Underperform → Neutral
2022-10-07	Hochstufung	Citigroup	Sell → Neutral
2022-09-26	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2022-04-18	Herabstufung	Piper Sandler	Neutral → Underweight
2021-10-18	Herabstufung	BofA Securities	Neutral → Underperform
2021-07-09	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-06-14	Herabstufung	Citigroup	Neutral → Sell
2020-12-18	Herabstufung	JP Morgan	Neutral → Underweight
2020-11-11	Bestätigt	Cowen	Market Perform
2020-10-13	Hochstufung	BofA Securities	Underperform → Neutral
2020-09-29	Hochstufung	ABN Amro	Sell → Hold
2020-07-16	Herabstufung	Scotiabank	Sector Outperform → Sector Perform
2020-04-13	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2020-03-09	Herabstufung	BofA/Merrill	Buy → Underperform
2020-03-09	Herabstufung	Evercore ISI	Outperform → In-line
2020-01-31	Bestätigt	Cowen	Market Perform
2020-01-30	Resumed	Johnson Rice	Buy
2020-01-14	Eingeleitet	Bernstein	Mkt Perform
2020-01-02	Herabstufung	Stifel	Buy → Hold
2019-12-31	Bestätigt	Cowen	Market Perform
2019-07-10	Hochstufung	BofA/Merrill	Neutral → Buy
2019-02-25	Hochstufung	Tudor Pickering	Hold → Buy
2018-12-19	Herabstufung	Credit Suisse	Outperform → Neutral
2018-12-11	Herabstufung	JP Morgan	Overweight → Neutral
2018-11-16	Hochstufung	Guggenheim	Neutral → Buy
2018-11-01	Hochstufung	ABN Amro	Sell → Buy
2018-10-29	Bestätigt	Cowen	Market Perform

Finanzdaten der Core Laboratories Inc-Aktie (CLB)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	526.52	523.85	509.79	489.74	470.25
Cost of revenue USD (M)	417.59	420.52	-	-	-
Operating expenses USD (M)	-	-	455.15	448.21	424.99
Operating income USD (M)	56.47	58.56	54.64	41.52	45.26
Income before tax USD (M)	45.90	46.19	41.21	29.95	36.11
Income tax expense USD (M)	15.51	14.03	-4.19	10.30	15.89
Net income USD (M)	30.39	32.15	37.03	19.66	20.22
Basic EPS USD/shares	0.64	0.67	0.79	0.42	0.43
Diluted EPS USD/shares	0.63	0.66	0.77	0.42	0.42
Basic weighted shares shares (M)	46.43	46.90	46.68	46.33	46.01
Diluted weighted shares shares (M)	47.03	47.69	47.52	46.81	46.69

Core Laboratories Inc-Aktie (CLB) Insiderhandel

Tattoli Mark DamianOct 01 '26
SVP, Gen Counsel & Secretary
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
700
Wert ($)
0
#Aktien Gesamt
28,365
Teo Sow HangOct 01 '26
CAO & Treasurer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
250
Wert ($)
0
#Aktien Gesamt
8,917
Teo Sow HangAug 01 '26
CAO & Treasurer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
440
Wert ($)
0
#Aktien Gesamt
8,775
Tattoli Mark DamianAug 01 '26
SVP, Gen Counsel & Secretary
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
250
Wert ($)
0
#Aktien Gesamt
27,764
Bruno LawrenceJul 31 '26
Chairman and CEO
Transaktion
Buy
Kosten
$10.78
#Aktien
5,000
Wert ($)
53,900
#Aktien Gesamt
262,438
Tattoli Mark DamianMay 01 '26
SVP, Gen Counsel & Secretary
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
250
Wert ($)
0
#Aktien Gesamt
27,611
Temeng KwakuApr 01 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
8,069
Wert ($)
0
#Aktien Gesamt
33,597
Murray KatherineApr 01 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
8,069
Wert ($)
0
#Aktien Gesamt
29,290
ANASTASIO CURTApr 01 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
8,069
Wert ($)
0
#Aktien Gesamt
23,805
Klingensmith Harvey RobertApr 01 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
8,069
Wert ($)
0
#Aktien Gesamt
50,031

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Tattoli Mark Damian	SVP, Gen Counsel & Secretary	Oct 01 '26	Option Exercise	$0.00	700	0	28,365
Teo Sow Hang	CAO & Treasurer	Oct 01 '26	Option Exercise	$0.00	250	0	8,917
Teo Sow Hang	CAO & Treasurer	Aug 01 '26	Option Exercise	$0.00	440	0	8,775
Tattoli Mark Damian	SVP, Gen Counsel & Secretary	Aug 01 '26	Option Exercise	$0.00	250	0	27,764
Bruno Lawrence	Chairman and CEO	Jul 31 '26	Buy	$10.78	5,000	53,900	262,438
Tattoli Mark Damian	SVP, Gen Counsel & Secretary	May 01 '26	Option Exercise	$0.00	250	0	27,611
Temeng Kwaku	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	33,597
Murray Katherine	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	29,290
ANASTASIO CURT	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	23,805
Klingensmith Harvey Robert	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	50,031

Core Laboratories Inc Aktie (CLB) Neueste Nachrichten

Nov 03, 2026

CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions - TradingView

Nov 03, 2026

CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions - Zacks Investment Research

Nov 03, 2026

Nov 02, 2026

Core Laboratories N.V. (CLB) Seasonal returns chart - Yahoo Finance UK

Nov 02, 2026

Weekly Recap: Revenue growth and Reservoir Description margin gain - TradingView

Nov 02, 2026

Oct 31, 2026

The most interesting analyst questions from Core Laboratories’s Q3 earnings call - Yahoo Finance

Oct 31, 2026